1-10 of 10
Mubarak Al-Mansour
Close
Sort by
Journal Articles

Impact of Therapy Sequence on Survival Outcomes Among Patients with Relapsed or Refractory Mature T and NK Cell Neoplasms: A Global Retrospective Cohort Study

Mark N Sorial, Min Jung Koh, Leora Boussi, Jessy Xinyi Han, Luke Peng, Ijeoma Julie Eche-Ugwu, Rui Duan, Matthew M. Lei, Eliana Miranda, Carlos Chiattone, Robert Stuver, Steven M. Horwitz, Maria J. Fernandez Turizo, Sean McCabe, Mwanasha Hamuza Merrill, Eric Jacobsen, Jin Seok Kim, Yu Ri Kim, Jae Yong Cho, Hasmukh Jain, Manju Sengar, Thomas Eipe, Tanuja Shet, Shambhavi Singh, Uvette Lou, Hesham Raghib, Judith Gabler, Min Ji Koh, Carrie Van Der Weyden, Miles Prince, Ramzi Hamouche, Tinatin Muradashvili, Francine M. Foss, Marianna Gentilini, Beatrice Casadei, Pier Luigi Zinzani, Takeshi Okatani, Noriaki Yoshida, Sang Eun Yoon, Won Seog Kim, Girisha Panchoo, Zainab Mohamed, Estelle Verburgh, Jackielyn Cuenca Alturas, Mubarak Al Mansour, Josie Ford, Martina Manni, Massimo Federico, Owen A. O'Connor, Maria Elena Cabrera, Enrica Marchi, Changyu Shen, Devavrat Shah, Salvia Jain
Journal: Blood
Blood (2023) 142 (Supplement 1): 3080.
https://doi.org/10.1182/blood-2023-182341
Published: 2023
Journal Articles

Novel Causal Inference Method Estimates Treatment Effects of Contemporary Drugs in a Global Cohort of Patients with Relapsed and Refractory Mature T-Cell and NK-Cell Neoplasms

Min Jung Koh, Leora Boussi, Jessy Xinyi Han, Luke Peng, Mark N Sorial, Ijeoma Julie Eche-Ugwu, Eliana Miranda, Carlos Chiattone, Robert Stuver, Steven M. Horwitz, Maria J. Fernandez Turizo, Sean McCabe, Mwanasha Hamuza Merrill, Eric Jacobsen, Jin Seok Kim, Yu Ri Kim, Jae Yong Cho, Thomas Eipe, Tanuja Shet, Hasmukh Jain, Manju Sengar, Shambhavi Singh, Judith Gabler, Min Ji Koh, Carrie Van Der Weyden, Miles Prince, Ramzi Hamouche, Tinatin Muradashvili, Francine M. Foss, Marianna Gentilini, Beatrice Casadei, Pier Luigi Zinzani, Takeshi Okatani, Noriaki Yoshida, Sang Eun Yoon, Won Seog Kim, Girisha Panchoo, Zainab Mohamed, Estelle Verburgh, Jackielyn Cuenca Alturas, Mubarak Al Mansour, Josie Ford, Martina Manni, Massimo Federico, Owen A. O'Connor, Maria Elena Cabrera, Changyu Shen, Enrica Marchi, Devavrat Shah, Salvia Jain
Journal: Blood
Blood (2023) 142 (Supplement 1): 1703.
https://doi.org/10.1182/blood-2023-185881
Published: 2023
Journal Articles

Incorporation of Machine Learning Tools to Predict Global Outcomes for Patients with Relapsed and Refractory Peripheral T and NK/T-Cell Lymphomas in the Contemporary Era

Leora S Boussi, Min Jung Koh, Xinyi Han, Luke Peng, Min Ji Koh, Ijeoma Eche, Josie Germain Ford, Shambhavi Singh, Eliana Miranda, Carlos S. Chiattone, Carrie Van Der Weyden, Henry Miles Prince, Francine M. Foss, Sang Eun Yoon, Won-Seog Kim, Girisha Panchoo, Estelle Verburgh, Jackielyn Cuenca Alturas, Mubarak Al-mansour, Martina Manni, Massimo Federico, Maria Elena Cabrera, Beatrice Casadei, Pier Luigi Zinzani, Noriaki Yoshida, Takeshi Okatani, Mwanasha H. Merrill, Eric D Jacobsen, Owen A. O'Connor, Enrica Marchi, Salvia Jain
Journal: Blood
Blood (2022) 140 (Supplement 1): 10976–10978.
https://doi.org/10.1182/blood-2022-162944
Published: 2022
Journal Articles

Use of Positron Emission Tomography in Patients with Classical Hodgkin Lymphoma Outside of Europe and North America: Results from the International, Multi-Center, Retrospective B-Holistic Study

Burhan Ferhanoglu, Marta Zerga, Mubarak Al-mansour, Tae Min Kim, Su-Peng Yeh, Yuqin Song, Amado J Karduss, Gayane Tumyan, Soon Thye Lim, Silvia Rivas-Vera, Yok Lam Kwong, Kwang-Wei Wu, Zhongwen Huang, Mark Hertzberg
Journal: Blood
Blood (2021) 138 (Supplement 1): 1397.
https://doi.org/10.1182/blood-2021-145838
Published: 2021
Journal Articles

Results from the International, Multi-Center, Retrospective B-Holistic Study: Describing Treatment Pathways and Outcomes for Classical Hodgkin Lymphoma

Burhan Ferhanoglu, MD, Tae Min Kim, MD PhD, Amado Karduss, MD, David Brittain, MBBCh, FC Path, Cert Clin Haem, Gayane Tumyan, Mubarak Al Mansour, Marta Zerga, MD, Yuqin Song, MD PhD, Silvia Rivas-Vera, MD, Yok Lam Kwong, MD FRCP, Soon Thye Lim, MBBS, MRCP, Su-Peng Yeh, MD, Arif Abdillah, MD, Zhongwen Huang, Mehul Dalal, PhD, Hui Wan, MD PhD, Mark Hertzberg, MBBS PhDFRACP FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–34.
https://doi.org/10.1182/blood-2020-134885
Published: 2020
Journal Articles

Interim Analysis Results from an International, Multi-Centre, Non-Interventional Retrospective Study to Describe Treatment Pathways, Outcomes, and Resource Use in Patients with Classical Hodgkin Lymphoma: B-CD30+ Hodgkin Lymphoma International Multi-Centre Retrospective Study of Treatment Practices and Outcomes (B-HOLISTIC)

Burhan Ferhanoglu, MD, Tae Min Kim, Gayane Tumyan, DMSc, MD PhD, Su-Peng Yeh, MD, David Brittain, MBBCh, FC Path, Cert Clin Haem, Amado Karduss, MD, Yok Lam Kwong, MD FRCP, Soon Thye Lim, MBBS, MRCP, FAMS, Mubarak Al Mansour, MD, Silvia Rivas-Vera, MD, Yuqin Song, MD PhD, Marta Zerga, MD, Julie Blair, PhD MD MPhil, Mehul Dalal, PhD, Hui Wan, MD PhD, Mark Hertzberg
Journal: Blood
Blood (2018) 132 (Supplement 1): 2917.
https://doi.org/10.1182/blood-2018-99-111146
Published: 2018
Journal Articles

Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis

Clinical Trials & Observations
Katharine H. Xing, Joseph M. Connors, Anky Lai, Mubarak Al-Mansour, Laurie H. Sehn, Diego Villa, Richard Klasa, Tamara Shenkier, Randy D. Gascoyne, Brian Skinnider, Kerry J. Savage
Journal: Blood
Blood (2014) 123 (23): 3567–3573.
https://doi.org/10.1182/blood-2013-12-541078
Published: 2014
Journal Articles

The Outcome of Advanced Stage Nodular Lymphocyte Predominant Hodgkin's Lymphoma (NLPHL) Compared to Classical Hodgkin's Lymphoma (CHL): A Matched Pair Analysis

Katharine He Xing, MD, Joseph M. Connors, MD, Mubarak Al-Mansour, MD, Randy D. Gascoyne, MD, Brian Skinnider, MD, Kerry J. Savage, MD MSc
Journal: Blood
Blood (2012) 120 (21): 1531.
https://doi.org/10.1182/blood.V120.21.1531.1531
Published: 2012
Journal Articles

Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome

Clinical Trials & Observations
Kerry J. Savage, Brian Skinnider, Mubarak Al-Mansour, Laurie H. Sehn, Randy D. Gascoyne, Joseph M. Connors
Journal: Blood
Blood (2011) 118 (17): 4585–4590.
https://doi.org/10.1182/blood-2011-07-365932
Published: 2011
Journal Articles

Incorporation of ABVD Increases Cure Rates of Patients with Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)

Kerry Joanne Savage, MD, MSc, Brian Skinnider, MD, Mubarak Al Mansour, MD, Laurie H Sehn, MD, MPH, Randy D. Gascoyne, MD, Joseph M. Connors, MD
Journal: Blood
Blood (2010) 116 (21): 3887.
https://doi.org/10.1182/blood.V116.21.3887.3887
Published: 2010